Physicians' Academy for Cardiovascular Education

The future perspectives for care for patients with high Lp(a)

10' education - May 27, 2016 - Innsbruck, Germany - Prof. Erik Stroes, MD PhD – Academic Medical Center, Amsterdam, The Netherlands - FRIDAY, MAY 27, 2016, lunch symposium at Lp(a) symposium prior to EAS

Video navigation menu

  • Elevated Lp(a) levels are prevalent and associated with elevated CV risk 0:01
  • Elevated Lp(a) levels may be implicated in those with unexplained CV risk 1:28
  • What is needed to improve care for individuals with high Lp(a) levels? 3:09
  • Proposed underlying pathogenic pathways of Lp(a)'s atherogenicity 3:46
  • Identifying subjects and high-risk families 5:40
  • Therapeutic options to lower Lp(a) 7:01

Disclosures

Prof. Erik Stroes MD PhD – is Chairman, Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, The Netherlands

Funding

The PACE foundation received funding for this session via an unrestricted educational grant from Amgen

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: